000148314 001__ 148314
000148314 005__ 20240229112700.0
000148314 0247_ $$2doi$$a10.1146/annurev-genet-120417-031642
000148314 0247_ $$2pmid$$apmid:31794268
000148314 0247_ $$2ISSN$$a0066-4197
000148314 0247_ $$2ISSN$$a1545-2948
000148314 0247_ $$2altmetric$$aaltmetric:72388765
000148314 037__ $$aDKFZ-2019-02872
000148314 041__ $$aeng
000148314 082__ $$a570
000148314 1001_ $$0P:(DE-He78)551bb92841f634070997aa168d818492$$aJones, David$$b0$$eFirst author$$udkfz
000148314 245__ $$aThe Power of Human Cancer Genetics as Revealed by Low-Grade Gliomas.
000148314 260__ $$aPalo Alto, Calif.$$bAnnual Review$$c2019
000148314 3367_ $$2DRIVER$$aarticle
000148314 3367_ $$2DataCite$$aOutput Types/Journal article
000148314 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1578386901_31737$$xReview Article
000148314 3367_ $$2BibTeX$$aARTICLE
000148314 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000148314 3367_ $$00$$2EndNote$$aJournal Article
000148314 500__ $$aEA: B360
000148314 520__ $$aThe human brain contains a vast number of cells and shows extraordinary cellular diversity to facilitate the many cognitive and automatic commands governing our bodily functions. This complexity arises partly from large-scale structural variations in the genome, evolutionary processes to increase brain size, function, and cognition. Not surprisingly given recent technical advances, low-grade gliomas (LGGs), which arise from the glia (the most abundant cell type in the brain), have undergone a recent revolution in their classification and therapy, especially in the pediatric setting. Next-generation sequencing has uncovered previously unappreciated diverse LGG entities, unraveling genetic subgroups and multiple molecular alterations and altered pathways, including many amenable to therapeutic targeting. In this article we review these novel entities, in which oncogenic processes show striking age-related neuroanatomical specificity (highlighting their close interplay with development); the opportunities they provide for targeted therapies, some of which are already practiced at the bedside; and the challenges of implementing molecular pathology in the clinic.
000148314 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0
000148314 588__ $$aDataset connected to CrossRef, PubMed,
000148314 7001_ $$aBandopadhayay, Pratiti$$b1
000148314 7001_ $$aJabado, Nada$$b2
000148314 773__ $$0PERI:(DE-600)1470448-1$$a10.1146/annurev-genet-120417-031642$$gVol. 53, no. 1, p. 483 - 503$$n1$$p483 - 503$$tAnnual review of genetics$$v53$$x1545-2948$$y2019
000148314 909CO $$ooai:inrepo02.dkfz.de:148314$$pVDB
000148314 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)551bb92841f634070997aa168d818492$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000148314 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000148314 9141_ $$y2019
000148314 915__ $$0StatID:(DE-HGF)0400$$2StatID$$aAllianz-Lizenz / DFG
000148314 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000148314 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000148314 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000148314 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000148314 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bANNU REV GENET : 2017
000148314 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000148314 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000148314 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000148314 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000148314 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000148314 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000148314 915__ $$0StatID:(DE-HGF)1040$$2StatID$$aDBCoverage$$bZoological Record
000148314 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000148314 915__ $$0StatID:(DE-HGF)1120$$2StatID$$aDBCoverage$$bBIOSIS Reviews Reports And Meetings
000148314 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bANNU REV GENET : 2017
000148314 9201_ $$0I:(DE-He78)B360-20160331$$kB360$$lPediatric Glioma$$x0
000148314 980__ $$ajournal
000148314 980__ $$aVDB
000148314 980__ $$aI:(DE-He78)B360-20160331
000148314 980__ $$aUNRESTRICTED